Literature DB >> 11089751

Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications.

B Adamik1, J Kübler-Kielb, B Golebiowska, A Gamian, A Kübler.   

Abstract

OBJECTIVES: To examine the hypothesis that nitrite/nitrate, neopterin, and procalcitonin (PCT) levels can be useful predictors of sepsis-associated mortality and predictors of the postoperative complications after cardiopulmonary bypass (CPB).
DESIGN: Prospective clinical study.
SETTING: Intensive care unit of the Medical University Hospital. PATIENTS: 41 patients with sepsis, 42 patients subjected to open heart surgery with CPB, and 30 healthy volunteers. MEASUREMENTS AND
RESULTS: Nitrite/nitrate, neopterin, and PCT levels were measured in septic patients as soon as sepsis was recognized and then on the 2nd, 3rd, and 5th days of treatment. Statistically significant differences between survivors and nonsurvivors were found for neopterin and PCT. The area under receiver operating characteristic curve (AUC) for both parameters as predictors of mortality was above 0.8. The nitrite/nitrate level was also higher in nonsurvivors, but the AUC remained below 0.8, which indicates poor predictive power. The same parameters were measured in patients undergoing cardiac surgery before, during and after CPB establishment. The development of post-operative complications was correlated with increased postoperative neopterin and PCT levels. Additionally, neopterin was found as an early marker for the prognosis of postoperative complications, since patients who developed organ dysfunction had had elevated concentration of this parameter even before surgery (AUC 0.83). Measurement of NO metabolite levels was less specific and less sensitive.
CONCLUSIONS: Our results confirm the value of PCT and neopterin measurement as diagnostic tools in monitoring the clinical course of patients in intensive care units.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089751     DOI: 10.1007/s001340000610

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  16 in total

Review 1.  Procalcitonin in acute cardiac patients.

Authors:  Claudio Picariello; Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

2.  Risk factors for sepsis and endocarditis and long-term survival following coronary artery bypass grafting.

Authors:  Ioannis K Toumpoulis; Constantine E Anagnostopoulos; Stavros K Toumpoulis; Joseph J De Rose; Daniel G Swistel
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

3.  Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery.

Authors:  Serdar Celebi; Ozge Koner; Ferdi Menda; Huriye Balci; Alican Hatemi; Kubilay Korkut; Figen Esen
Journal:  Intensive Care Med       Date:  2006-04-28       Impact factor: 17.440

Review 4.  Role of Procalcitonin in the Prognosis of Mortality in Patients Admitted to the Intensive Care Unit: A Review Study.

Authors:  Mahdiye Jafari; Farzaneh Fazeli; Majid Sezavar; Sara Khashkhashi; Benyamin Fazli; Nooshin Abdollahpour; Alireza Sedaghat
Journal:  Tanaffos       Date:  2021-04

Review 5.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

Review 6.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.

Authors:  Christoph Sponholz; Yasser Sakr; Konrad Reinhart; Frank Brunkhorst
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients.

Authors:  Michael Meisner; Heide Adina; Joachim Schmidt
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

8.  Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.

Authors:  C Picariello; C Lazzeri; M Chiostri; G F Gensini; S Valente
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010

9.  Serum neopterin levels in patients with replicative and nonreplicative HBV carriers.

Authors:  Ilknur Kaleli; Melek Demir; Nural Cevahir; Mustafa Yilmaz; Suleyman Demir
Journal:  BMC Infect Dis       Date:  2006-10-31       Impact factor: 3.090

10.  Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome.

Authors:  Marta Los Arcos; Corsino Rey; Andrés Concha; Alberto Medina; Belen Prieto
Journal:  BMC Pediatr       Date:  2008-04-30       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.